{"contentid": 488413, "importid": NaN, "name": "Nasal spray works against COVID-19 variants", "introduction": "A nasal spray designed to block the novel coronavirus, from Austrian drug developer Marinomed Biotech, has been shown to inactivate new, rapidly spreading variants.", "content": "<p>A nasal spray designed to block the novel coronavirus, from Austrian drug developer Marinomed Biotech (VSE: MARI), has been shown to inactivate new, rapidly spreading variants.</p>\n<p>The Korneuburg-based firm said that<em> in vitro</em> testing showed the product was effective against the SARS-CoV-2 wildtype as well as three variants - the so-called British, South-African and Brazilian types.</p>\n<p>The firm said its data demonstrate that its marketed over-the-counter lozenges, nasal and throat sprays will &ldquo;continue to effectively contribute to combatting the COVID-19 pandemic.&rdquo;</p>\n<h2>Carragelose platform</h2>\n<p>Marinomed has previously focused on its Marinosolv platform, which is designed to increase the efficacy of hardly soluble compounds for the treatment of sensitive tissues.</p>\n<p>Spun out of the veterinary university in Vienna, the company was founded in 2006 with the goal of extracting drugs from marine fauna, especially corals.</p>\n<p>The firm&rsquo;s latest technology, Carragelose, is being developed to target infections such as COVID-19, by inactivating them and preventing them from infecting cells.</p>\n<p>The product, a sulfated polymer derived from red seaweed, works by forming a layer on the mucosa wrapping entering viruses, thereby inactivating them.</p>\n<p>Chief scientific officer Eva Prieschl-Grassauer said: &ldquo;We are very confident in these results that show Carragelose inactivates SARS-CoV-2, independent of the mutations we tested.&rdquo;</p>\n<p>She added: &ldquo;With these new results we confirmed the hypothesis that our Carragelose-based products continue to be effective also against the mutations of concern currently emerging strongly. We believe that this will hold true for any future variants.&rdquo;</p>\n<p>Marinomed is holder of the IP rights to Carragelose and has licensed the product for marketing in Europe, parts of Asia, Canada, and Australia.</p>", "date": "2021-04-21 10:30:00", "meta_title": NaN, "meta_keywords": "variants, nasal, spray, Marinomed, COVID-, designed, Carragelose, works, block, coronavirus, Austrian, drug, developer, Biotech, spreading, rapidly, shown", "meta_description": "A nasal spray designed to block the novel coronavirus, from Austrian drug developer Marinomed Biotech, has been shown to inactivate new, rapidly spreading varia", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-21 10:30:13", "updated": "2021-04-21 13:33:07", "access": NaN, "url": "https://www.thepharmaletter.com/article/nasal-spray-works-against-covid-19-variants", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "marinomedbig.jpg", "image2id": "marinomedsmall.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Anti-virals, Infectious diseases", "topic_tag": "Coronavirus, Drug Trial, Focus On, Research", "geography_tag": "Austria", "company_tag": "Marinomed", "drug_tag": "Carragelose", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-21 10:30:00"}